GABRIELLE KEC: Open Payments
NPI 1215306360 · ALGONQUIN, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,119 in 56 payments from 15 companies in 2025. Trend: 2023 $344 · 2024 $663 · 2025 $1,119
Food & beverage: $1,119
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $209 |
| Neurocrine BioSciences, Inc. | 3 | $160 |
| Lundbeck LLC | 7 | $135 |
| Neos Therapeutics, LP | 5 | $104 |
| Corium, LLC | 5 | $103 |
| Axsome Therapeutics, Inc. | 4 | $85 |
| Otsuka America Pharmaceutical, Inc. | 3 | $78 |
| Janssen Pharmaceuticals, Inc | 3 | $65 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $49 |
| Alkermes, Inc. | 2 | $37 |
Products named: VRAYLAR, INGREZZA, REXULTI, Azstarys, Auvelity, ABILIFY ASIMTUFII, SPRAVATO, Adzenys XR-ODT.
Industry payments across IL — which companies pay providers there.
